Is cyclosporine withdrawal a therapeutic option in renal transplant recipients with chronic allograft dysfunction?

Related Experiment Video

Updated: Sep 25, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

D Ducloux1

  • 1Department of Nephrology, Dialysis and Renal Transplantation, CHU Saint Jacques, Besançon, France. ducloux@chu-besancon.fr

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|May 30, 2003
PubMed

Insights

Chronic allograft nephropathy (CAN) is linked to cyclosporine (CsA) toxicity. Switching to Mycophenolate Mofetil (MMF) or Sirolimus (SRL) may help reverse chronic rejection and improve graft survival.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • Chronic allograft nephropathy (CAN) is the primary cause of kidney transplant failure.
  • Both immunologic and non-immunologic factors contribute to CAN.
  • Cyclosporine (CsA) nephrotoxicity is a significant factor in CAN development.

Purpose of the Study:

  • To review the evidence supporting a therapeutic approach for CAN.
  • To analyze the mechanisms of CsA nephrotoxicity and its role in CAN.
  • To evaluate the potential of alternative immunosuppressants like MMF and SRL in managing CAN.

Main Methods:

  • Review of existing literature on CsA nephrotoxicity.
  • Analysis of histopathologic findings in CAN.
  • Examination of animal models and clinical studies investigating MMF and SRL for CAN.

Main Results:

  • CsA contributes to CAN through nephrotoxicity.
  • Mycophenolate Mofetil (MMF) and Sirolimus (SRL) show potential in preventing and reversing chronic rejection.
  • A two-step approach involving CsA withdrawal and MMF/SRL use is supported by evidence.

Conclusions:

  • Switching from CsA to MMF or SRL may mitigate CAN.
  • Alternative immunosuppressants offer a promising strategy for managing chronic kidney transplant rejection.
  • Further research and clinical application of this therapeutic approach are warranted.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...